一项定性研究,以了解在转移性结直肠癌中进行复杂干预的随机对照试验的挑战
Niamh McKigney1, Jenny Seligmann2, Maureen Twiddy3
1Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. N.McKigney@leeds.ac.uk.
Trials
|March 20, 2025
概括
对转移性结直肠癌 (mCRC) 进行随机对照试验 (RCT) 面临挑战. 本研究确定了改善高级mCRC患者试验设计和交付的策略.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 胃肠病学 胃肠病学
背景情况:
- 对转移性结直肠癌 (mCRC) 的干预措施很常见,但缺乏随机对照试验 (RCT) 的高质量证据.
- 在mCRC中,对切除,切除和化学栓塞等治疗方法的现有证据有限.
- 需要提高支持mCRC管理的数据质量.
研究的目的:
- 探讨在对先进的mCRC进行RCT时遇到的挑战.
- 确定克服这些挑战的潜在策略.
- 加强未来mCRC临床试验的设计和交付.
主要方法:
- 一项涉及从事mCRC试验的专业人员的定性研究.
- 在线进行了半结构化的深度访谈.
- 对采访数据进行了主题内容分析.
主要成果:
- 采访了来自6项mCRC试验的12名参与者.
- 出现了四个主要主题:试验流程,组织/结构问题,试验设计和mCRC特定因素.
- 挑战包括资金,道德认可,设备,患者偏好,物流,疾病进展和息治疗.
结论:
- 实施有针对性的策略可以改善mCRC试验的整个生命周期.
- 改进范围从最初的试验开发到设置,招聘和跟进.
- 解决已确定的挑战对于推动mCRC研究至关重要.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.2K
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
1.7K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
